NO FEE UNLESS WE WIN
FREE CASE REVIEW
817-870-2102
Injured by a defective drug or medical device? We litigate against pharmaceutical and device manufacturers.
Abuse of Opioids Prompts FDA Scrutiny: The FDA has been evaluating the appropriate use of opioid products very carefully over the past…
Continue reading »The Food and Drug Administration (“FDA”) has new labeling requirements for extended-release and long-acting (“ER/LA”) opioid pain relievers to ensure their safe…
Continue reading »In July, 2011, the US Food and Drug Administration (FDA) issued a proposal for guidelines relating to mobile medical applications. (more…)
Continue reading »The first DePuy ASR bellwether trial in the consolidated California state court litigation was scheduled to begin this month in San Francisco…
Continue reading »The Headquarters Marine Corps Exchange buyer has notified Camp Pendleton exchanges to ban the sale of OxyElite Pro after the recent reports…
Continue reading »The United States Air Force has issued a warning to service men and women regarding the use of OxyElite Pro. Many service…
Continue reading »ABC and CBS News are reporting that the US Food and Drug Administration has recalled “a couple” of technical experts to help…
Continue reading »Summary: On October 8, 2013, the Center for Disease Control and Prevention (“CDC”) issued a Health Advisory for OxyElite Pro due to…
Continue reading »According to an FDA news release posted on September 20, 2013, the U.S. Food and Drug Administration (“FDA”) is launching a new…
Continue reading »Summary On August 15, 2013, the U.S. Food and Drug Administration (F.D.A.) issued a safety announcement advising the public that manufacturers of…
Continue reading »Free, confidential case review with a board-certified Texas trial lawyer. No fee unless we win.
Get a Free Case Review Call 817-870-2102